Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2006
10/26/2006WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/26/2006US20060241259 for photopolymerization; photography, relief imaging; color filters
10/26/2006US20060241168 administering a protein kinase B activating agent comprising (R)-5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline; treating depression, posttraumatic stress disorder, Parkinson's disease, Alzheimer's diseases
10/26/2006US20060241155 TNF-alpha production inhibitors
10/26/2006US20060241153 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
10/26/2006US20060241149 Chemical compounds
10/26/2006US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis
10/26/2006US20060241140 Imidazolamino compounds
10/26/2006US20060241137 Triazole compounds and the therapeutic use thereof
10/26/2006US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006US20060241119 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2006US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006US20060241114 Derivatives of azasugars as anticancer agents
10/26/2006US20060241111 inhibitors of coagulation factor Xa such as 1-(5-chlorothien-2-ylcarbonyl)-4-[4-(3-oxomorpholin-4-yl)phenyl]-2-propylsemicarbazide, used for preventing thrombosis, infarction, arteriosclerosis, inflammation, bleeding, angina pectoris, restenosis, intermittent claudication and treatment of tumors
10/26/2006US20060241105 To control arthropods (including insects and arachnids) and helminths (including nematodes) also valuable to protect timber from sawflies, beetles or termites or use in veterinary medicine; 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-(N-benzyloxy-2-amidino)-5-methylamino-4-trifluoromethylsulfonylpyrazole
10/26/2006US20060240048 Pyridine derivatives as cb2 receptor modulators
10/26/2006US20060237716 Material and cell structure for storage applications
10/26/2006CA2610446A1 Nitrogen-containing heterocyclic compound
10/26/2006CA2605778A1 Fused heterocyclic compound
10/26/2006CA2605059A1 Oxindole compounds and their uses as therapeutic agents
10/26/2006CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism
10/26/2006CA2602247A1 Piperazine-substituted benzothiophenes for treatment of mental disorders
10/26/2006CA2601979A1 2,3 substituted pyrazine sulfonamides
10/25/2006EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006EP1713798A2 C10 cyclopentyl ester substituted taxanes
10/25/2006EP1713778A1 Benzazepine derivatives as histamine h3 antagonists
10/25/2006EP1713772A1 Novel piperidines as chemokine modulators (ccr)
10/25/2006EP1713484A2 Compounds and methods of use
10/25/2006EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
10/25/2006EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase
10/25/2006EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
10/25/2006EP1265606B1 Cell adhesion inhibitors
10/25/2006EP1089998B1 Epothilone derivatives and their synthesis and use
10/25/2006CN1852905A N-substituted benzimidazolyl c-kit inhibitors
10/25/2006CN1852902A Method for the production of 4-(4-aminophenyl)-3-morpholinon
10/25/2006CN1852897A Gabanergic modulators
10/25/2006CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
10/25/2006CN1852895A 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents
10/25/2006CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases
10/25/2006CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006CN1281585C Cyclic diamine compounds having fused-ring groups
10/24/2006US7126013 Mono-, oligo- and polymers comprising fluorene and aryl groups
10/24/2006US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006US7126004 Thiazoline acid derivatives
10/24/2006US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006US7125904 Cardiovascular disorders; hypotensive agents; congestive heart failure
10/24/2006US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006US7125879 Prevention reproduction of virus
10/24/2006US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006US7125840 Substituted dipeptides as growth hormone secretagogues
10/24/2006CA2442615C A reduced ignition propensity smoking article
10/24/2006CA2261848C Cell adhesion inhibitors
10/24/2006CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006CA2246678C Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides
10/24/2006CA2223094C Phenylpyridazinones
10/24/2006CA2222517C Agents for use against parasitic protozoa
10/24/2006CA2214752C Herbicidal or fungicidal sulphonylaminocarbonyltriazolinones with halogenated alk(en)oxy substituents
10/24/2006CA2211411C Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides
10/24/2006CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines
10/24/2006CA2158400C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenes
10/19/2006WO2006109846A1 Triazole derivative and the use thereof
10/19/2006WO2006109633A1 Substituted indole compound
10/19/2006WO2006109084A1 Dna-pk inhibitors
10/19/2006WO2006109081A1 Dna-pk inhibitors
10/19/2006WO2006109058A1 New bicyclic angiotensin ii agonists
10/19/2006WO2006109056A1 New tricyclic angiotensin ii agonists
10/19/2006WO2006109048A1 New tricyclic angiotensin ii agonists
10/19/2006WO2006108791A2 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
10/19/2006WO2006108709A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
10/19/2006WO2006108701A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
10/19/2006WO2006083841A3 Therapeutic esters
10/19/2006WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use
10/19/2006US20060235223 Variolin derivatives and their use as antitumor agents
10/19/2006US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors
10/19/2006US20060235069 Benzamide modulators of metabotropic glutamate receptors
10/19/2006US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
10/19/2006US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors
10/19/2006US20060235014 Inhibitors of p38
10/19/2006US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
10/19/2006DE102005017301A1 Substituierte Chromanderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Substituted chroman derivatives, processes for their preparation and their use as anti-inflammatories
10/19/2006CA2604797A1 New tricyclic angiotensin ii agonists
10/19/2006CA2604038A1 New tricyclic angiotensin ii agonists
10/19/2006CA2603637A1 Dna-pk inhibitors
10/19/2006CA2603254A1 New bicyclic angiotensin ii agonists
10/18/2006EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors
10/18/2006EP1712549A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/18/2006EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
10/18/2006EP1711809A2 Time-temperature indicator based on valence isomerizations
10/18/2006EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
10/18/2006EP1711181A1 Quinoline derivatives and use thereof as mycobacterial inhibitors